138 related articles for article (PubMed ID: 27034421)
21. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
22. Studying Microtubule Dynamics in Human Neurons: Two-Dimensional Microtubule Tracing and Kymographs in iPSC- and SH-SY5Y-Derived Neurons for Tau Research.
Allroggen N; Breuer H; Bachmann S; Bell M; Zempel H
Methods Mol Biol; 2024; 2754():561-580. PubMed ID: 38512690
[TBL] [Abstract][Full Text] [Related]
23. Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport.
Butler VJ; Salazar DA; Soriano-Castell D; Alves-Ferreira M; Dennissen FJA; Vohra M; Oses-Prieto JA; Li KH; Wang AL; Jing B; Li B; Groisman A; Gutierrez E; Mooney S; Burlingame AL; Ashrafi K; Mandelkow EM; Encalada SE; Kao AW
Hum Mol Genet; 2019 May; 28(9):1498-1514. PubMed ID: 30590647
[TBL] [Abstract][Full Text] [Related]
24. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
25. [Expression of tau-related protein in spinal cord of patients with Alzheimer's disease].
GUO YJ; WANG LN; ZHU MW; ZHANG HH; HU YZ; HAN ZT; LI JM; WANG DX
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):161-4. PubMed ID: 21575385
[TBL] [Abstract][Full Text] [Related]
26. Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways.
Christensen KR; Beach TG; Serrano GE; Kanaan NM
Acta Neuropathol Commun; 2019 Feb; 7(1):29. PubMed ID: 30819250
[TBL] [Abstract][Full Text] [Related]
27. Cleavage of human tau at Asp421 inhibits hyperphosphorylated tau induced pathology in a Drosophila model.
Chi H; Sun L; Shiu RH; Han R; Hsieh CP; Wei TM; Lo CC; Chang HY; Sang TK
Sci Rep; 2020 Aug; 10(1):13482. PubMed ID: 32778728
[TBL] [Abstract][Full Text] [Related]
28. Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.
Cox K; Combs B; Abdelmesih B; Morfini G; Brady ST; Kanaan NM
Neurobiol Aging; 2016 Nov; 47():113-126. PubMed ID: 27574109
[TBL] [Abstract][Full Text] [Related]
29. Dynein Dysfunction Prevents Maintenance of High Concentrations of Slow Axonal Transport Cargos at the Axon Terminal: A Computational Study.
Kuznetsov IA; Kuznetsov AV
J Biomech Eng; 2023 Jul; 145(7):. PubMed ID: 36795013
[TBL] [Abstract][Full Text] [Related]
30. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
Lomoio S; Scherini E; Necchi D
Brain Res; 2009 Nov; 1297():198-206. PubMed ID: 19703431
[TBL] [Abstract][Full Text] [Related]
31. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
32. Emergence of directional bias in tau deposition from axonal transport dynamics.
Torok J; Maia PD; Verma P; Mezias C; Raj A
PLoS Comput Biol; 2021 Jul; 17(7):e1009258. PubMed ID: 34314441
[TBL] [Abstract][Full Text] [Related]
33. The Role of Tau in the Post-synapse.
Regan P; Cho K
Adv Exp Med Biol; 2019; 1184():113-121. PubMed ID: 32096033
[TBL] [Abstract][Full Text] [Related]
34. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
Brandt R; Hundelt M; Shahani N
Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
[TBL] [Abstract][Full Text] [Related]
35. Brief update on different roles of tau in neurodegeneration.
Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
[TBL] [Abstract][Full Text] [Related]
36. Mechanical Effects of Dynamic Binding between Tau Proteins on Microtubules during Axonal Injury.
Ahmadzadeh H; Smith DH; Shenoy VB
Biophys J; 2015 Dec; 109(11):2328-37. PubMed ID: 26636944
[TBL] [Abstract][Full Text] [Related]
37. Presence of axonal paired helical filament-tau in Alzheimer's disease: submicroscopic localization.
Bondareff W; Harrington CR; McDaniel SW; Wischik CM; Roth M
J Neurosci Res; 1994 Aug; 38(6):664-9. PubMed ID: 7807582
[TBL] [Abstract][Full Text] [Related]
38. Processes induced by tau expression in Sf9 cells have an axon-like microtubule organization.
Baas PW; Pienkowski TP; Kosik KS
J Cell Biol; 1991 Dec; 115(5):1333-44. PubMed ID: 1955477
[TBL] [Abstract][Full Text] [Related]
39. Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo.
Planel E; Krishnamurthy P; Miyasaka T; Liu L; Herman M; Kumar A; Bretteville A; Figueroa HY; Yu WH; Whittington RA; Davies P; Takashima A; Nixon RA; Duff KE
J Neurosci; 2008 Nov; 28(48):12798-807. PubMed ID: 19036972
[TBL] [Abstract][Full Text] [Related]
40. Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tau.
Xie C; Soeda Y; Shinzaki Y; In Y; Tomoo K; Ihara Y; Miyasaka T
J Neurochem; 2015 Oct; 135(1):19-26. PubMed ID: 26134402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
